Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

LONDON BRIEFING: Emis takeover and BT Openreach get watchdog scrutiny

17th Mar 2023 07:53

(Alliance News) - London's FTSE 100 is called to open higher on Friday, ending a tumultuous week in the green. Read More

GSK lauds trial findings; asthma drug backed for review in China

14th Mar 2023 09:41

(Alliance News) - GSK PLC said on Tuesday its asthma drug was accepted for review in China, while it also reported a trial for a drug to treat an infectious disease met its primary endpoint. Read More

Sareum says GSK's Sierra returns clinical study reports to CRT Pioneer

6th Mar 2023 11:19

(Alliance News) - Sareum Holdings PLC on Monday said that GSK PLC subsidiary Sierra Oncology Inc has completed the return of the clinical study reports relating to SRA737 to Sarerum's co-development partner CRT Pioneer Fund LP. Read More

TOP NEWS: Haleon revenue up; records loss due to GSK demerger costs

2nd Mar 2023 11:13

(Alliance News) - Haleon PLC on Thursday said revenue was up, as it declares its inaugural dividend following its GSK split. Read More

LONDON BROKER RATINGS: Numis cuts BT to 'sell'; Citigroup cuts Babcock

2nd Mar 2023 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

LONDON MARKET OPEN: CRH shares jump as it plans US primary listing

2nd Mar 2023 09:13

(Alliance News) - Stock prices in London were lower early Thursday, with the FTSE 100 index being spared from a steeper fall thanks to a jump in CRH shares and a weaker pound. Read More

LONDON BRIEFING: Taylor Wimpey expects house completions to drop

2nd Mar 2023 07:57

(Alliance News) - Stocks were called to open flat in London, with market attention on a raft of corporate earnings, as well as a eurozone inflation reading at 1000 GMT. Read More

US FDA panel supports GSK vaccine ahead of approval decision

2nd Mar 2023 07:00

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration's advisory committee voted to support its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

2nd Mar 2023 06:56

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading. Read More

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

27th Feb 2023 09:26

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday: Read More

LONDON MARKET CLOSE: FTSE 100 struggles, but European peers rise

23rd Feb 2023 17:00

(Alliance News) - Stock prices in London closed mixed on Thursday, with blue-chips ending in the red on renewed concerns of higher rates in the US, as well as a host of stocks going ex-dividend. Read More

GSK, Pfizer venture says HIV injectable therapy preferred in trial

23rd Feb 2023 09:02

(Alliance News) - GSK PLC on Thursday said that ViiV Healthcare has found that its injectable Cabenuva is as effective as the daily oral Biktarvy in treating HIV-1. Read More

GSK, Pfizer joint venture gets EU marketing approval for HIV treatment

22nd Feb 2023 13:13

(Alliance News) - ViiV Healthcare on Wednesday said it received marketing authorisation from the European Commission for Triumeq PD, a treament for children living with HIV Read More

UK dividends calendar - next 7 days

16th Feb 2023 15:47

Read More

GSK hails positive phase III trial results for RSV vaccine candidate

16th Feb 2023 09:04

(Alliance News) - GSK PLC on Thursday said a New England Journal of Medicine publication announced positive phase III trial results for its respiratory syncytial virus vaccine candidate for older adults. Read More

LONDON BROKER RATINGS: Shell, Glencore, Smurfit and abrdn ratings cut

10th Feb 2023 09:52

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning: Read More

TOP NEWS: GSK's Jemperli wins approval and trial evaluation in US

10th Feb 2023 08:04

(Alliance News) - GSK PLC on Friday said its drug Jemperli won a regular approval for a form of endometrial cancer and is set to be evaluated for a form of advanced rectal cancer in the US. Read More

GSK gets FDA approval for drug to treat anaemia in adults on dialysis

2nd Feb 2023 09:26

(Alliance News) - GSK PLC on Thursday said its Jesduvroq drug has been approved by the US Food & Drug Administration for anaemia of chronic kidney disease in adults on dialysis. Read More

LONDON BROKER RATINGS: Goldman Sachs cuts Standard Chartered

2nd Feb 2023 09:19

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning: Read More

LONDON MARKET OPEN: GSK profit up; Vodafone growth slows; US Fed ahead

1st Feb 2023 09:13

(Alliance News) - Stock prices in London opened higher on Wednesday, as investors expect to see the US central bank continue to slow the pace of its interest rate hikes. Read More

FTSE 100 Latest
Value10,506.25
Change44.30